2023. 06. 14
Cellusion CEO, Dr. Hatou gave a company presentation at the BIO International Convention 2023 in Boston, on the status of development, including the progress of its lead program CLS001, First-in-Human…
2023. 06. 14
Japan Innovation Night was a pitch event organized by JETRO & Japan Desk of CIC to bring together Japanese bio ventures in conjunction with the BIO International Conference 2023 in Boston. In addi…
2023. 04. 10
For more details, please see the following link.NHK WORLD-JAPAN News: Researchers announce first iPS cell transplant for cornea disease
2022. 08. 16
Hatou In 2015, I founded Cellusion. In the early stages of R&D, we were creating CECSi cells, corneal endothelial cell substitute from iPSC in the laboratory. Once the therapeutic effects wer…
2022. 08. 10
Our Reason for Supporting Cellusion Yamagishi KII’s mission statement is “Let us help your research, your invention, your innovation change the world.” As a venture capital, we aim to contr…
